These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 9785130

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Morphologic endometrium changes with tamoxifen].
    Dallenbach-Hellweg G, Hahn U, Schmidt D.
    Zentralbl Gynakol; 1996; 118(6):365-9. PubMed ID: 8768015
    [Abstract] [Full Text] [Related]

  • 23. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
    Semiglazov VF, Maksimov SIa, Bulgatova EA, Meshkova IE, Chepik OF, Berstein LM.
    Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
    [Abstract] [Full Text] [Related]

  • 24. Endometrial polyps during menopause: characterization and significance.
    Orvieto R, Bar-Hava I, Dicker D, Bar J, Ben-Rafael Z, Neri A.
    Acta Obstet Gynecol Scand; 1999 Nov; 78(10):883-6. PubMed ID: 10577618
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Postmenopausal hemorrhage and endometrial cancer in tamoxifen therapy].
    Krause A, Gerber B.
    Zentralbl Gynakol; 1994 Feb; 116(1):44-7. PubMed ID: 8147180
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Significance of "normal" endometrial cells in cervical cytology from asymptomatic postmenopausal women receiving hormone replacement therapy.
    Montz FJ.
    Gynecol Oncol; 2001 Apr; 81(1):33-9. PubMed ID: 11277646
    [Abstract] [Full Text] [Related]

  • 33. Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen.
    Kesim MD, Aydin Y, Atis A, Mandiraci G.
    Climacteric; 2008 Jun; 11(3):252-7. PubMed ID: 18568790
    [Abstract] [Full Text] [Related]

  • 34. Endometrial pathologies associated with postmenopausal tamoxifen treatment.
    Cohen I.
    Gynecol Oncol; 2004 Aug; 94(2):256-66. PubMed ID: 15297160
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Genomic changes in endometrial polyps associated with tamoxifen show no evidence for its action as an external carcinogen.
    Dal Cin P, Timmerman D, Van den Berghe I, Wanschura S, Kazmierczak B, Vergote I, Deprest J, Neven P, Moerman P, Bullerdiek J, Van den Berghe H.
    Cancer Res; 1998 Jun 01; 58(11):2278-81. PubMed ID: 9622058
    [Abstract] [Full Text] [Related]

  • 37. Clinicopathologic study of 56 patients with endometrial cancer during or after adjuvant tamoxifen use for their breast cancers.
    Hachisuga T, Saito T, Kigawa J, Ohwada M, Yamazawa K, Yasue A, Iwasaka T, Sugiyama T, Kita T, Nagai N.
    Gynecol Oncol; 2004 Oct 01; 95(1):139-44. PubMed ID: 15385123
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Tamoxifen, endometrial cancer risk and liquid based cytology. A paradigmatic case].
    Fambrini M, Buccoliero AM, Pieralli A, Andersson KL, Mattei A, Scarselli G, Taddei G, Marchionni M.
    Minerva Ginecol; 2011 Oct 01; 63(5):465-70. PubMed ID: 21926955
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.